The present study aimed to validate a survival score for patients treated with palliative thoracic irradiation for lung cancer. The impact of all 3 prognostic factors used to assign the three-tiered score was confirmed. However a large discrepancy in median survival of prognostically favorable patients was seen (8 vs. 38 months). Thus additional studies are needed in order to inform therapeutic decisions in this group.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2jMT48H
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου